These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37246725)

  • 1. Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats.
    Kurtz M; Fabrès V; Dumont R; Chetboul V; Chahory S; Saponaro V; Trehiou E; Poissonnier C; Passavin P; Jondeau C; Bott M; Buronfosse T; Benchekroun G
    J Vet Intern Med; 2023; 37(4):1348-1357. PubMed ID: 37246725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats.
    Fabrès V; Dumont R; Garcia M; Rosenberg D; Rannou B; Kurtz M; Benchekroun G
    J Vet Intern Med; 2023; 37(4):1341-1347. PubMed ID: 36988582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the oral fludrocortisone suppression test for diagnosing primary hyperaldosteronism in cats.
    Djajadiningrat-Laanen SC; Galac ; Boevé MH; Boroffka SA; Naan EC; IJzer J; Kooistra HS
    J Vet Intern Med; 2013; 27(6):1493-9. PubMed ID: 24627898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Aldosterone/Creatinine Ratio After Fludrocortisone Suppression Consistent with PHA in a Cat.
    Koutinas CK; Soubasis NC; Djajadiningrat-Laanen SC; Kolia E; Theodorou K
    J Am Anim Hosp Assoc; 2015; 51(5):338-41. PubMed ID: 26355586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline primary hyperaldosteronism.
    Schulman RL
    Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):353-9. PubMed ID: 20219494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum aldosterone and cortisol concentrations before and after suppression with fludrocortisone in cats: a pilot study.
    Matsuda M; Behrend EN; Kemppainen R; Refsal K; Johnson A; Lee H
    J Vet Diagn Invest; 2015 May; 27(3):361-8. PubMed ID: 25901003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of aldosterone-secreting adrenocortical tumors in cats by unilateral adrenalectomy: 10 cases (2002-2012).
    Lo AJ; Holt DE; Brown DC; Schlicksup MD; Orsher RJ; Agnello KA
    J Vet Intern Med; 2014; 28(1):137-43. PubMed ID: 24372771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.
    Coleman AE; Brown SA; Traas AM; Bryson L; Zimmering T; Zimmerman A
    J Vet Intern Med; 2019 Mar; 33(2):478-488. PubMed ID: 30851066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin-angiotensin-aldosterone system upregulation.
    Evans J; Ward J; Domenig O; Mochel JP; Creevy K
    J Vet Intern Med; 2022 Jan; 36(1):272-278. PubMed ID: 34859924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperaldosteronism: expanding the diagnostic net.
    Djajadiningrat-Laanen S; Galac S; Kooistra H
    J Feline Med Surg; 2011 Sep; 13(9):641-50. PubMed ID: 21872791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppression test to diagnose hyperaldosteronism in cats].
    Haneveld JK
    Tijdschr Diergeneeskd; 2014 Mar; 139(3):34-5. PubMed ID: 24701787
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder.
    Kooistra HS
    Vet Clin North Am Small Anim Pract; 2020 Sep; 50(5):1053-1063. PubMed ID: 32653266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary hyperaldosteronism in cats].
    Willi B; Kook PH; Quante S; Boretti F; Sieber-Ruckstuhl NS; Grest P; Scherrer O; Riond B; Hofmann-Lehmann R; Nussberger J; Reusch CE
    Schweiz Arch Tierheilkd; 2012 Dec; 154(12):529-37. PubMed ID: 23188765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hyperaldosteronism in two cats.
    Flood SM; Randolph JF; Gelzer AR; Refsal K
    J Am Anim Hosp Assoc; 1999; 35(5):411-6. PubMed ID: 10493417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperaldosteronism in the cat: a series of 13 cases.
    Ash RA; Harvey AM; Tasker S
    J Feline Med Surg; 2005 Jun; 7(3):173-82. PubMed ID: 15922224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.
    Glaus TM; Elliott J; Herberich E; Zimmering T; Albrecht B
    J Vet Intern Med; 2019 Mar; 33(2):413-422. PubMed ID: 30561059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent disorders of cats with diabetes mellitus and arterial systolic hypertension.
    Williams JG; Hess RS
    J Feline Med Surg; 2023 Jul; 25(7):1098612X231187691. PubMed ID: 37470682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple corticosteroid abnormalities in cats with hyperaldosteronism.
    Langlois DK; Mazaki-Tovi M; Harro CC; Refsal KR
    J Vet Intern Med; 2021 Sep; 35(5):2152-2158. PubMed ID: 34331479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of plasma aldosterone concentration and treatment with eplerenone on the survival of cats with chronic kidney disease.
    Kai M; Ohishi T; Hikasa Y
    Can Vet J; 2022 Dec; 63(12):1226-1235. PubMed ID: 36467377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.